Details for Patent: 9,241,910

✉ Email this page to a colleague

Which drugs does patent 9,241,910 protect, and when does it expire?

Patent 9,241,910 protects DEXILANT SOLUTAB and is included in one NDA.

This patent has thirty-one patent family members in twenty-six countries.

Summary for Patent: 9,241,910

Patent landscape, scope, and claims:

Title:	Orally-disintegrating solid preparation
Abstract:	The present invention provides an orally-disintegrating solid preparation such as a tablet produced by tabletting fine granules showing controlled release of a pharmaceutically active ingredient and an additive, and the like, and the orally-disintegrating solid preparation containing fine granules coated with a coating layer containing a polymer affording a casting film having an elongation at break of about 100-about 700%. With the preparation, breakage of fine granules during tabletting can be suppressed in the production of an orally-disintegrating solid preparation containing fine granules showing controlled release of a pharmaceutically active ingredient.
Inventor(s):	Kurasawa; Takashi (Osaka, JP), Watanabe; Yasuko (Osaka, JP), Omachi; Yoshihiro (Osaka, JP)
Assignee:	Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:	12/921,731
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form; Delivery;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,241,910

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Takeda Pharms Usa	DEXILANT SOLUTAB	dexlansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	208056-001	Jan 26, 2016		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,241,910

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2008-061673	Mar 11, 2008
Japan	2008-334920	Dec 26, 2008

PCT Information
PCT Filed	March 10, 2009	PCT Application Number:	PCT/JP2009/054983
PCT Publication Date:	September 17, 2009	PCT Publication Number:	WO2009/113703

International Family Members for US Patent 9,241,910

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	070863	⤷ Subscribe
Australia	2009224254	⤷ Subscribe
Brazil	PI0909439	⤷ Subscribe
Canada	2717947	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.